MedPayRx was at the 2017 International Association for Cannabinoid Medicines (IACM) Conference in Cologne.
We attended (as press but also as a nascent start up), the IACM’s 9th Conference on Cannabinoids in Medicine last week.
All I can say is just wow. The level of understanding about the endocannabinoid system not to mention cannabis science is exploding.
While this was more of an academic than ostensibly “industry” conference, this is absolutely where the science of today will become the innovation of tomorrow. Not only was this gathering sponsored by leading companies in the cannabis space in Germany if not Europe, but investors were clearly present among the international gathering of medical doctors and research PhDs there to disseminate canna science breakthroughs that are absolutely astounding.
On that front, the speaker list was a who’s who of the leading names in cannabis globally. What was even cooler was to see the next leading edge of innovation in the younger generations (and both Gen X and Y are on the front lines of this.)
From a start up perspective, however, this conference was just further confirmation that we are in the right place at the right time. We help solve a major pain point for industry, insurance and patients alike, while providing cutting edge customer service.
I headed home from Köln (Cologne) via one of my favourite rail trips so far in Germany – from Koblenz via Mainz along the Main. We have lots to do, and many follow-ups to make, but we know we are heading in the right direction.
There are more exciting developments ahead for the fall.
For more detailed coverage of the conference, please see the article in Cannabis Industry Journal.